New Zealand markets open in 2 hours 17 minutes

Plus Therapeutics, Inc. (PSTV)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.8330+0.0130 (+0.71%)
As of 03:36PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 10.37M
Enterprise value 10.91M
Trailing P/E 0.75
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)25.08
Price/book (mrq)3.76
Enterprise value/revenue 18.19
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 3-13.33%
S&P500 52-week change 324.16%
52-week high 33.2100
52-week low 30.9700
50-day moving average 31.9892
200-day moving average 31.8121

Share statistics

Avg vol (3-month) 381.18k
Avg vol (10-day) 337.2k
Shares outstanding 55.7M
Implied shares outstanding 65.7M
Float 85.59M
% held by insiders 11.93%
% held by institutions 111.74%
Shares short (28 Jun 2024) 4234.07k
Short ratio (28 Jun 2024) 44.65
Short % of float (28 Jun 2024) 44.11%
Short % of shares outstanding (28 Jun 2024) 44.10%
Shares short (prior month 31 May 2024) 4171.28k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Aug 2019
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 301 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -193.49%
Operating margin (ttm)-196.72%

Management effectiveness

Return on assets (ttm)-69.96%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)6.08M
Revenue per share (ttm)1.67
Quarterly revenue growth (yoy)231.40%
Gross profit (ttm)N/A
EBITDA -11.27M
Net income avi to common (ttm)-11.77M
Diluted EPS (ttm)-2.9200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.22M
Total cash per share (mrq)0.56
Total debt (mrq)3.76M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.41
Book value per share (mrq)-1.13

Cash flow statement

Operating cash flow (ttm)-11.57M
Levered free cash flow (ttm)-7.29M